Refine by
Therapeutic Potential Articles & Analysis: This-Year
2 news found
Ace Therapeutics, a preclinical contract research provider dedicated to offering comprehensive one-stop services, released the expansion of its research capabilities in the area of depression through the introduction of comprehensive depression-related behavior tests in its preclinical investigation processes. ...
Glis2 is a critical component of the cilia-dependent cyst activation (CDCA) pathway and has emerged as a potential therapeutic target for ADPKD. This application note highlights the use of the Precellys Evolution tissue homogenizer to prepare normal and cystic kidney tissues from various mouse models of ADPKD. ...